Anđela Horvat

6PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
The p53 Isoforms as Potential Biomarkers in Different Cancer Entities.

|Jan 25, 2025
Neurotoxic Effect of Myricitrin in Copper-Induced Oxidative Stress Is Mediated by Increased Intracellular Ca2+ Levels and ROS/p53/p38 Axis.

Ignacija Vlašić, Antonio Krstačić-Galić, Anđela Horvat

|Sep 14, 2024
Mitochondrial NME6 Influences Basic Cellular Processes in Tumor Cells In Vitro.

Bastien Proust, Anđela Horvat, Ana Tadijan

|Dec 23, 2023
Flavonols as a Potential Pharmacological Intervention for Alleviating Cognitive Decline in Diabetes: Evidence from Preclinical Studies.

Anđela Horvat, Ignacija Vlašić, Jasminka Štefulj

|Jan 08, 2023
p53 Family in Resistance to Targeted Therapy of Melanoma.

Ignacija Vlašić, Anđela Horvat, Ana Tadijan

|Sep 09, 2022
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance.

Martina Radić, Ignacija Vlašić, Maja Jazvinšćak Jembrek

Pageof 1

Frequent Collaborators

6 joint publications

Ignacija Vlašić

4 joint publications

Maja Jazvinšćak Jembrek

4 joint publications

Ana Tadijan

2 joint publications

Nada Oršolić